ArticleJournal of Alzheimer's disease & Parkinsonism2022

Risk of Developing Alzheimer's Disease and Related Dementias in ALLHAT Trial Participants Receiving Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker with 18 Years of Follow-Up.

Xianglin L Du et al.PubMed ↗Full text ↗

No numbers read from the abstract.